8-K: Bellevue Life Sciences Acquisition Corp. Extends Maturity Dates on Promissory Notes

Bellevue Life Sciences Acquisition Corp. has amended promissory notes with Jun Chul Whang and Josh Pan, extending their maturity dates to the earlier of March 31, 2025, or the completion of a business combination.

Summary

• Bellevue Life Sciences Acquisition Corp. has extended the maturity dates of two promissory notes.
• The first note, with a principal of $75,000, was issued to Jun Chul Whang, a board member.
• The second note, with a principal of $60,000, was issued to Josh Pan, a member of Bellevue Capital Management, LLC.
• Both notes' maturity dates have been extended to the earlier of March 31, 2025, or the date the company completes an initial business combination.
• No other terms of the promissory notes were changed.

Sentiment

Score: 6

Explanation: The document is neutral, detailing a routine extension of debt obligations. It's not particularly positive or negative, but rather an expected step for a company in its position.

Positives

• The extension of the maturity dates provides the company with additional time before repayment is due.
• The company has not changed any other terms of the promissory notes, maintaining the original agreements.

Negatives

• The company still has a financial obligation to repay the promissory notes.
• The extension of the maturity date may indicate the company has not yet completed a business combination.

Risks

• The company's ability to repay the promissory notes depends on its ability to complete a business combination or secure other funding.
• Failure to complete a business combination by March 31, 2025, could lead to repayment issues.

Future Outlook

The company's future financial obligations related to these notes are tied to the completion of a business combination or the March 31, 2025 deadline.

Management Comments

• The company, through CEO Kuk Hyoun Hwang, signed the amendments to the promissory notes.

Industry Context

This type of promissory note extension is common for SPACs (Special Purpose Acquisition Companies) like Bellevue Life Sciences Acquisition Corp. as they seek to complete a business combination.

Comparison to Industry Standards

• Many SPACs use promissory notes to fund operations while searching for a merger target.
• The terms of these notes, such as the interest rate and maturity date, are often negotiated with insiders or sponsors.
• The extension of maturity dates is a common practice when a SPAC is taking longer than expected to find a suitable target.
• Comparable companies would be other SPACs that have not yet completed a business combination and have similar financing arrangements.

Related Party Transactions

• The promissory note to Jun Chul Whang, a board member, is a related party transaction.
• The promissory note to Josh Pan, a member of the company's sponsor, is a related party transaction.

Stakeholder Impact

• Shareholders may be concerned about the company's ability to complete a business combination and repay its debts.
• Creditors, specifically Jun Chul Whang and Josh Pan, have had their repayment dates extended.

Next Steps

• The company needs to either complete a business combination or repay the promissory notes by March 31, 2025.
• The company will likely continue to seek a suitable business combination target.

Key Dates

Keywords

promissory note, maturity date, business combination, debt, financing, amendment, Bellevue Life Sciences Acquisition Corp.